Company Analysis
Sign in

ImmuCell Corporation (ICCC)

Nasdaq: ICCC · In Vitro & In Vivo Diagnostic Substances · Portland, ME · filing with the SEC since 1995
Full chart Alerts Compare
Grade5.3
◀ Past 4.8● Present 5.8▶ Future 4.9
1 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 30, 2026Mar 28, 2025Apr 1, 2024Mar 29, 2023Mar 30, 2022Mar 30, 2021Mar 27, 2020Mar 22, 2019Mar 29, 2018Mar 30, 2017
Revenue27,644,17426,493,16917,471,66918,567,96219,242,96915,342,20413,722,87210,986,29710,431,0919,543,961
Cost of revenue16,198,97118,552,12513,602,38510,919,18310,587,0408,479,3786,983,1525,792,3925,209,7344,123,266
Gross profit11,445,2037,941,0443,869,2847,648,7798,655,9296,862,8266,739,7205,193,9055,221,3575,420,695
Research and development3,041,8803,898,5824,394,8524,493,8724,168,5184,354,6273,687,6093,516,6192,046,5641,244,335
Sales and marketing3,553,3753,466,0723,088,2153,190,0332,503,9262,167,8992,318,1122,084,9031,892,8231,831,317
General and administrative3,200,6432,216,5492,134,2952,263,8171,726,1001,720,6531,687,9071,738,9531,524,8151,454,839
Total operating expenses9,795,8989,581,2039,617,3629,947,7228,398,5448,243,1797,693,6286,640,4755,464,2024,530,491
Operating income1,649,305-1,640,159-5,748,078-2,298,943257,385-1,380,353-953,908-1,446,570-242,845890,204
Interest expense493,384568,725475,598348,536314,359·····
Interest and investment income158,70977,70296,570153,10018,81027,440120,752r14,30116,90954,662
Other income (expense), net··-21,893-187,190-326,512348,100-313,505···
Total non-operating income (expense)-2,677,762-506,414-21,893·······
Income before income taxes-1,028,457-2,146,573-5,769,971-2,486,133-69,127-1,032,253-1,267,413-1,860,051-438,480758,322
Income tax expense11,57010,0564,6277,6729,165-10,13628,174461,620-270,333249,874
Net income to non-controlling interests···-2,493,805-78,292-1,022,117····
Net income-1,040,027-2,156,629-5,774,598-2,493,805-78,292-1,022,117-1,295,587-2,321,671-168,147508,448
Earnings per share, basic-0.12-0.26-0.75-0.32-0.01-0.14-0.19-0.42-0.030.12
Earnings per share, diluted-0.12-0.26-0.75-0.32-0.01-0.14-0.19-0.42-0.030.12
Weighted average shares, basic9,026,1308,167,2447,747,6867,745,1227,592,2907,213,3296,818,9605,486,1544,949,2134,225,789
Weighted average shares, diluted9,026,1308,167,2447,747,6867,745,1227,592,2907,213,3296,818,9605,486,1544,949,2134,336,229
Weighted average shares, basic and diluted·····7,213,3296,818,9605,486,154··
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:Revenues
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:SalesRevenueGoodsNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfRevenue
us-gaap:CostOfGoodsAndServicesSold
us-gaap:CostOfGoodsSold
Gross profit revenue less the cost of what it soldus-gaap:GrossProfit
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
us-gaap:InterestIncomeOther
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income to non-controlling interests the share that belongs to minority holdersus-gaap:NetIncomeLossAttributableToNoncontrollingInterest
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ICCC · research, not advice